Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

SYGNIS Reports Financial Results For The Second Quarter And First Six Months Of 2017

  • Post author:Sam
  • Post published:August 2, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingSYGNIS Reports Financial Results For The Second Quarter And First Six Months Of 2017

Regeneron to Terminate Its Antibody Discovery Pact With Sanofi

  • Post author:Sam
  • Post published:August 2, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingRegeneron to Terminate Its Antibody Discovery Pact With Sanofi

Bruker Corporation Announces Acquisition Of Field-Portable Platform For Fast And Universal Immunoassay-Detection Of Bacteria, Viruses And Toxins

  • Post author:Sam
  • Post published:August 2, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingBruker Corporation Announces Acquisition Of Field-Portable Platform For Fast And Universal Immunoassay-Detection Of Bacteria, Viruses And Toxins

Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease

  • Post author:Sam
  • Post published:August 2, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingJohnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease

Exelixis Announces Second Quarter 2017 Financial Results And Provides Corporate Update

  • Post author:Sam
  • Post published:August 2, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingExelixis Announces Second Quarter 2017 Financial Results And Provides Corporate Update

Former Google Exec Steps Down as GRAIL CEO

  • Post author:Sam
  • Post published:August 2, 2017
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x430-grail-jeff-huber.jpg" NAME"Former Google Exec Steps Down as GRAIL CEO" ALT"Former Google Exec Steps Down as GRAIL CEO"August 3, 2017By Alex Keown, BioSpace.com Breaking News StaffMENLO PARK, Calif. Former ...…

Continue ReadingFormer Google Exec Steps Down as GRAIL CEO

Ocular Therapeutix to Slash Jobs After FDA Rejection

  • Post author:Sam
  • Post published:August 1, 2017
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Ocular Therapeutix to Slash Jobs After FDA Rejection" ALT"Ocular Therapeutix to Slash Jobs After FDA Rejection"August 2, 2017By Alex Keown, BioSpace.com Breaking News StaffBEDFORD, Mass. One... Source: BioSpace

Continue ReadingOcular Therapeutix to Slash Jobs After FDA Rejection

Keystone Heart to Accelerate Trials for a New Advanced Cerebral Embolic Protection Device

  • Post author:Sam
  • Post published:August 1, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingKeystone Heart to Accelerate Trials for a New Advanced Cerebral Embolic Protection Device

4 Clinical Projects Shelved From Pfizer???s Pipeline

  • Post author:Sam
  • Post published:August 1, 2017
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x425-pfizer.jpg" NAME"4 Clinical Projects Shelved From Pfizers Pipeline" ALT"4 Clinical Projects Shelved From Pfizers Pipeline"August 2, 2017By Alex Keown, BioSpace.com Breaking News StaffNEW YORK Since May, ... Source: BioSpace

Continue Reading4 Clinical Projects Shelved From Pfizer???s Pipeline

Boost For As Announce First Award Winners

  • Post author:Sam
  • Post published:August 1, 2017
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingBoost For As Announce First Award Winners
  • Go to the previous page
  • 1
  • …
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company